{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:24:44Z","timestamp":1778768684139,"version":"3.51.4"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s11427-024-3015-1","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T02:10:35Z","timestamp":1758852635000},"page":"101-118","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Metformin sensitizes non-small cell lung cancer to CDK4\/6 inhibitor treatment by reducing lysosomal trapping"],"prefix":"10.1007","volume":"69","author":[{"given":"Yaqi","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yalei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ni","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haijuan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lipan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongsheng","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Qie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"key":"3015_CR1","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1126\/science.aan6298","volume":"358","author":"M Abu-Remaileh","year":"2017","unstructured":"Abu-Remaileh, M., Wyant, G.A., Kim, C., Laqtom, N.N., Abbasi, M., Chan, S.H., Freinkman, E., and Sabatini, D.M. (2017). Lysosomal metabolomics reveals V-ATPase- and mTOR-dependent regulation of amino acid efflux from lysosomes. Science 358, 807\u2013813.","journal-title":"Science"},{"key":"3015_CR2","doi-asserted-by":"publisher","first-page":"e293","DOI":"10.1038\/cddis.2012.30","volume":"3","author":"Y Adar","year":"2012","unstructured":"Adar, Y., Stark, M., Bram, E.E., Nowak-Sliwinska, P., van den Bergh, H., Szewczyk, G., Sarna, T., Skladanowski, A., Griffioen, A.W., and Assaraf, Y.G. (2012). Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers. Cell Death Dis 3, e293.","journal-title":"Cell Death Dis"},{"key":"3015_CR3","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.ccell.2020.03.010","volume":"37","author":"M \u00c1lvarez-Fern\u00e1ndez","year":"2020","unstructured":"\u00c1lvarez-Fern\u00e1ndez, M., and Malumbres, M. (2020). Mechanisms of sensitivity and resistance to CDK4\/6 inhibition. Cancer Cell 37, 514\u2013529.","journal-title":"Cancer Cell"},{"key":"3015_CR4","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1200\/JCO.2005.05.064","volume":"23","author":"A Arnold","year":"2005","unstructured":"Arnold, A., and Papanikolaou, A. (2005). Cyclin D1 in breast cancer pathogenesis. J Clin Oncol 23, 4215\u20134224.","journal-title":"J Clin Oncol"},{"key":"3015_CR5","doi-asserted-by":"publisher","first-page":"e192553","DOI":"10.1001\/jamaoncol.2019.2553","volume":"5","author":"O Arrieta","year":"2019","unstructured":"Arrieta, O., Barr\u00f3n, F., Padilla, M.\u00c1.S., Avil\u00e9s-Salas, A., Ram\u00edrez-Tirado, L.A., Arguelles Jim\u00e9nez, M.J., Vergara, E., Zatarain-Barr\u00f3n, Z.L., Hern\u00e1ndez-Pedro, N., Cardona, A.F., et al. (2019). Effect of metformin plus tyrosine kinase inhibitors compared with tyrosine kinase inhibitors alone in patients with epidermal growth factor receptor-mutated lung adenocarcinoma: a phase 2 randomized clinical trial. JAMA Oncol 5, e192553.","journal-title":"JAMA Oncol"},{"key":"3015_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/jlb.57.2.275","volume":"57","author":"A Bidani","year":"1995","unstructured":"Bidani, A., and Heming, T.A. (1995). Effects of bafilomycin A1 on functional capabilities of LPS-activated alveolar macrophages. J Leukoc Biol 57, 275\u2013281.","journal-title":"J Leukoc Biol"},{"key":"3015_CR7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11427-021-2140-8","volume":"66","author":"Z Cai","year":"2023","unstructured":"Cai, Z., Wang, J., Li, Y., Shi, Q., Jin, L., Li, S., Zhu, M., Wang, Q., Wong, L.L., Yang, W., et al. (2023). Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4\/6 inhibitor in breast cancer that can be reversed by PI3K\/mTOR inhibitors. Sci China Life Sci 66, 94\u2013109.","journal-title":"Sci China Life Sci"},{"key":"3015_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nature20805","volume":"541","author":"Cancer Genome Atlas Research Network","year":"2017","unstructured":"Cancer Genome Atlas Research Network, Analysis Working Group: Asan University, BC Cancer Agency, Brigham and Women\u2019s Hospital, Broad Institute, Brown University, Case Western Reserve University, Dana-Farber Cancer Institute, Duke University, Greater Poland Cancer Center, et al. (2017). Integrated genomic characterization of oesophageal carcinoma. Nature, 541, 169\u2013175.","journal-title":"Nature"},{"key":"3015_CR9","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1007\/s11427-023-2343-y","volume":"66","author":"G Chen","year":"2023","unstructured":"Chen, G., Sun, L., Gu, X., Ai, L., Yang, J., Zhang, Z., Hou, P., Wang, Y., Ou, X., Jiang, X., et al. (2023). FSIP1 enhances the therapeutic sensitivity to CDK4\/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway. Sci China Life Sci 66, 2805\u20132817.","journal-title":"Sci China Life Sci"},{"key":"3015_CR10","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S1470-2045(23)00228-0","volume":"24","author":"X Chen","year":"2023","unstructured":"Chen, X., and Shen, K. (2023). Dalpiciclib in advanced breast cancer. Lancet Oncol 24, 578\u2013579.","journal-title":"Lancet Oncol"},{"key":"3015_CR11","doi-asserted-by":"publisher","first-page":"eabh1275","DOI":"10.1126\/sciadv.abh1275","volume":"7","author":"YC Chiu","year":"2021","unstructured":"Chiu, Y.C., Zheng, S., Wang, L.J., Iskra, B.S., Rao, M.K., Houghton, P.J., Huang, Y., and Chen, Y. (2021). Predicting and characterizing a cancer dependency map of tumors with deep learning. Sci Adv 7, eabh1275.","journal-title":"Sci Adv"},{"key":"3015_CR12","doi-asserted-by":"publisher","first-page":"c2181","DOI":"10.1136\/bmj.c2181","volume":"340","author":"J de Jager","year":"2010","unstructured":"de Jager, J., Kooy, A., Lehert, P., Wulffele, M.G., van der Kolk, J., Bets, D., Verburg, J., Donker, A.J.M., and Stehouwer, C.D.A. (2010). Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. BMJ 340, c2181.","journal-title":"BMJ"},{"key":"3015_CR13","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.jhep.2018.11.034","volume":"70","author":"S de Oliveira","year":"2019","unstructured":"de Oliveira, S., Houseright, R.A., Graves, A.L., Golenberg, N., Korte, B.G., Miskolci, V., and Huttenlocher, A. (2019). Metformin modulates innate immune-mediated inflammation and early progression of NAFLD-associated hepatocellular carcinoma in zebrafish. J Hepatol 70, 710\u2013721.","journal-title":"J Hepatol"},{"key":"3015_CR14","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s40265-021-01508-y","volume":"81","author":"S Dhillon","year":"2021","unstructured":"Dhillon, S. (2021). Trilaciclib: first approval. Drugs 81, 867\u2013874.","journal-title":"Drugs"},{"key":"3015_CR15","doi-asserted-by":"publisher","first-page":"4804","DOI":"10.1038\/s41467-022-32505-8","volume":"13","author":"L Dong","year":"2022","unstructured":"Dong, L., Xie, J., Wang, Y., Jiang, H., Chen, K., Li, D., Wang, J., Liu, Y., He, J., Zhou, J., et al. (2022). Mannose ameliorates experimental colitis by protecting intestinal barrier integrity. Nat Commun 13, 4804.","journal-title":"Nat Commun"},{"key":"3015_CR16","doi-asserted-by":"publisher","first-page":"eabb2210","DOI":"10.1126\/sciadv.abb2210","volume":"6","author":"A Fassl","year":"2020","unstructured":"Fassl, A., Brain, C., Abu-Remaileh, M., Stukan, I., Butter, D., Stepien, P., Feit, A.S., Bergholz, J., Michowski, W., Otto, T., et al. (2020). Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4\/6 inhibition. Sci Adv 6, eabb2210.","journal-title":"Sci Adv"},{"key":"3015_CR17","doi-asserted-by":"publisher","first-page":"eabc1495","DOI":"10.1126\/science.abc1495","volume":"375","author":"A Fassl","year":"2022","unstructured":"Fassl, A., Geng, Y., and Sicinski, P. (2022). CDK4 and CDK6 kinases: from basic science to cancer therapy. Science 375, eabc1495.","journal-title":"Science"},{"key":"3015_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lungcan.2006.09.024","volume":"55","author":"O Gautschi","year":"2007","unstructured":"Gautschi, O., Ratschiller, D., Gugger, M., Betticher, D.C., and Heighway, J. (2007). Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation. Lung Cancer 55, 1\u201314.","journal-title":"Lung Cancer"},{"key":"3015_CR19","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41568-022-00456-3","volume":"22","author":"S Goel","year":"2022","unstructured":"Goel, S., Bergholz, J.S., and Zhao, J.J. (2022). Targeting CDK4 and CDK6 in cancer. Nat Rev Cancer 22, 356\u2013372.","journal-title":"Nat Rev Cancer"},{"key":"3015_CR20","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1200\/JCO.2017.75.6155","volume":"35","author":"MP Goetz","year":"2017","unstructured":"Goetz, M.P., Toi, M., Campone, M., Sohn, J., Paluch-Shimon, S., Huober, J., Park, I.H., Tr\u00e9dan, O., Chen, S.C., Manso, L., et al. (2017). MONARCH 3: Abemaciclib as initial therapy for advanced breast cancer. J Clin Oncol 35, 3638\u20133646.","journal-title":"J Clin Oncol"},{"key":"3015_CR21","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.cmet.2023.12.007","volume":"36","author":"L Guarente","year":"2024","unstructured":"Guarente, L., Sinclair, D.A., and Kroemer, G. (2024). Human trials exploring anti-aging medicines. Cell Metab 36, 354\u2013376.","journal-title":"Cell Metab"},{"key":"3015_CR22","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.chembiol.2019.05.005","volume":"26","author":"M Hafner","year":"2019","unstructured":"Hafner, M., Mills, C.E., Subramanian, K., Chen, C., Chung, M., Boswell, S.A., Everley, R.A., Liu, C., Walmsley, C.S., Juric, D., et al. (2019). Multiomics profiling establishes the polypharmacology of FDA-approved CDK4\/6 inhibitors and the potential for differential clinical activity. Cell Chem Biol 26, 1067\u20131080.e8.","journal-title":"Cell Chem Biol"},{"key":"3015_CR23","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1111\/cas.14419","volume":"111","author":"H Hino","year":"2020","unstructured":"Hino, H., Iriyama, N., Kokuba, H., Kazama, H., Moriya, S., Takano, N., Hiramoto, M., Aizawa, S., and Miyazawa, K. (2020). Abemaciclib induces atypical cell death in cancer cells characterized by formation of cytoplasmic vacuoles derived from lysosomes. Cancer Sci 111, 2132\u20132145.","journal-title":"Cancer Sci"},{"key":"3015_CR24","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1056\/NEJMoa2114663","volume":"386","author":"GN Hortobagyi","year":"2022","unstructured":"Hortobagyi, G.N., Stemmer, S.M., Burris, H.A., Yap, Y.S., Sonke, G.S., Hart, L., Campone, M., Petrakova, K., Winer, E.P., Janni, W., et al. (2022). Overall survival with ribociclib plus letrozole in advanced breast cancer. N Engl J Med 386, 942\u2013950.","journal-title":"N Engl J Med"},{"key":"3015_CR25","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.cmet.2016.12.009","volume":"25","author":"JJ Howell","year":"2017","unstructured":"Howell, J.J., Hellberg, K., Turner, M., Talbott, G., Kolar, M.J., Ross, D.S., Hoxhaj, G., Saghatelian, A., Shaw, R.J., and Manning, B.D. (2017). Metformin inhibits hepatic mTORC1 signaling via dose-dependent mechanisms involving AMPK and the TSC complex. Cell Metab 25, 463\u2013471.","journal-title":"Cell Metab"},{"key":"3015_CR26","doi-asserted-by":"publisher","first-page":"4392","DOI":"10.3390\/ijms21124392","volume":"21","author":"J Hrab\u011bta","year":"2020","unstructured":"Hrab\u011bta, J., Belhajov\u00e1, M., \u0160ubrtov\u00e1, H., Merlos Rodrigo, M.A., Heger, Z., and Eckschlager, T. (2020). Drug sequestration in lysosomes as one of the mechanisms of chemoresistance of cancer cells and the possibilities of its inhibition. Int J Mol Sci 21, 4392.","journal-title":"Int J Mol Sci"},{"key":"3015_CR27","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1080\/15548627.2022.2125629","volume":"19","author":"M Hu","year":"2023","unstructured":"Hu, M., Chen, J., Liu, S., and Xu, H. (2023). The acid gate in the lysosome. Autophagy 19, 1368\u20131370.","journal-title":"Autophagy"},{"key":"3015_CR28","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1158\/0008-5472.CAN-22-3042","volume":"83","author":"X Huang","year":"2023","unstructured":"Huang, X., Sun, T., Wang, J., Hong, X., Chen, H., Yan, T., Zhou, C., Sun, D., Yang, C., Yu, T.C., et al. (2023). Metformin reprograms tryptophan metabolism to stimulate CD8+ T-cell function in colorectal cancer. Cancer Res 83, 2358\u20132371.","journal-title":"Cancer Res"},{"key":"3015_CR29","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1200\/JCO.20.02514","volume":"38","author":"SRD Johnston","year":"2020","unstructured":"Johnston, S.R.D., Harbeck, N., Hegg, R., Toi, M., Martin, M., Shao, Z.M., Zhang, Q.Y., Martinez Rodriguez, J.L., Campone, M., Hamilton, E., et al. (2020). Abemaciclib combined with endocrine therapy for the adjuvant treatment of HR+, HER2\u2212, node-positive, high-risk, early breast cancer (monarchE). J Clin Oncol 38, 3987\u20133998.","journal-title":"J Clin Oncol"},{"key":"3015_CR30","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1073\/pnas.1014641108","volume":"108","author":"P Kannan","year":"2011","unstructured":"Kannan, P., Brimacombe, K.R., Kreisl, W.C., Liow, J.S., Zoghbi, S.S., Telu, S., Zhang, Y., Pike, V.W., Halldin, C., Gottesman, M.M., et al. (2011). Lysosomal trapping of a radiolabeled substrate of P-glycoprotein as a mechanism for signal amplification in PET. Proc Natl Acad Sci USA 108, 2593\u20132598.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3015_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/1756-9966-30-101","volume":"30","author":"M Kosacka","year":"2011","unstructured":"Kosacka, M., Piesiak, P., Kowal, A., Go\u0142ecki, M., and Jankowska, R. (2011). Galectin-3 and cyclin D1 expression in non-small cell lung cancer. J Exp Clin Cancer Res 30, 101.","journal-title":"J Exp Clin Cancer Res"},{"key":"3015_CR32","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1158\/0008-5472.CAN-20-2275","volume":"81","author":"V Kumarasamy","year":"2021","unstructured":"Kumarasamy, V., Vail, P., Nambiar, R., Witkiewicz, A.K., and Knudsen, E.S. (2021). Functional determinants of cell cycle plasticity and sensitivity to CDK4\/6 inhibition. Cancer Res 81, 1347\u20131360.","journal-title":"Cancer Res"},{"key":"3015_CR33","first-page":"e1575","volume":"5","author":"C Lagampan","year":"2022","unstructured":"Lagampan, C., Poovorawan, N., and Parinyanitikul, N. (2022). Lactic acidosis, a potential toxicity from drug-drug interaction related to concomitant ribociclib and metformin in preexisting renal insufficiency: a case report. Cancer Rep 5, e1575.","journal-title":"Cancer Rep"},{"key":"3015_CR34","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1158\/2159-8290.CD-20-1726","volume":"12","author":"Q Li","year":"2022","unstructured":"Li, Q., Jiang, B., Guo, J., Shao, H., Del Priore, I.S., Chang, Q., Kudo, R., Li, Z., Razavi, P., Liu, B., et al. (2022). INK4 tumor suppressor proteins mediate resistance to CDK4\/6 kinase inhibitors. Cancer Discov 12, 356\u2013371.","journal-title":"Cancer Discov"},{"key":"3015_CR35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s13046-018-0938-5","volume":"37","author":"Y Li","year":"2018","unstructured":"Li, Y., Cao, F., Li, M., Li, P., Yu, Y., Xiang, L., Xu, T., Lei, J., Tai, Y.Y., Zhu, J., et al. (2018). Hydroxychloroquine induced lung cancer suppression by enhancing chemo-sensitization and promoting the transition of M2-TAMs to M1-like macrophages. J Exp Clin Cancer Res 37, 259.","journal-title":"J Exp Clin Cancer Res"},{"key":"3015_CR36","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/ncb3407","volume":"18","author":"Y Li","year":"2016","unstructured":"Li, Y., Xu, M., Ding, X., Yan, C., Song, Z., Chen, L., Huang, X., Wang, X., Jian, Y., Tang, G., et al. (2016). Protein kinase C controls lysosome biogenesis independently of mTORC1. Nat Cell Biol 18, 1065\u20131077.","journal-title":"Nat Cell Biol"},{"key":"3015_CR37","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1038\/s41388-019-0695-8","volume":"38","author":"S Llanos","year":"2019","unstructured":"Llanos, S., Megias, D., Blanco-Aparicio, C., Hern\u00e1ndez-Encinas, E., Rovira, M., Pietrocola, F., and Serrano, M. (2019). Lysosomal trapping of palbociclib and its functional implications. Oncogene 38, 3886\u20133902.","journal-title":"Oncogene"},{"key":"3015_CR38","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1038\/s41467-024-45796-w","volume":"15","author":"J Ma","year":"2024","unstructured":"Ma, J., Li, L., Ma, B., Liu, T., Wang, Z., Ye, Q., Peng, Y., Wang, B., Chen, Y., Xu, S., et al. (2024). MYC induces CDK4\/6 inhibitors resistance by promoting pRB1 degradation. Nat Commun 15, 1871.","journal-title":"Nat Commun"},{"key":"3015_CR39","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s13046-023-02768-0","volume":"42","author":"J Ma","year":"2023","unstructured":"Ma, J., Ma, R., Zeng, X., Zhang, L., Liu, J., Zhang, W., Li, T., Niu, H., Bao, G., Wang, C., et al. (2023). Lysosome blockade induces divergent metabolic programs in macrophages and tumours for cancer immunotherapy. J Exp Clin Cancer Res 42, 192.","journal-title":"J Exp Clin Cancer Res"},{"key":"3015_CR40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41586-022-04431-8","volume":"603","author":"T Ma","year":"2022","unstructured":"Ma, T., Tian, X., Zhang, B., Li, M., Wang, Y., Yang, C., Wu, J., Wei, X., Qu, Q., Yu, Y., et al. (2022). Low-dose metformin targets the lysosomal AMPK pathway through PEN2. Nature 603, 159\u2013165.","journal-title":"Nature"},{"key":"3015_CR41","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41392-020-0203-1","volume":"5","author":"Y Ma","year":"2020","unstructured":"Ma, Y., Zhu, Q., Liang, J., Li, Y., Li, M., Zhang, Y., Wang, X., Zeng, Y., and Jiao, Y. (2020). A CRISPR knockout negative screen reveals synergy between CDKs inhibitor and metformin in the treatment of human cancer in vitro and in vivo. Sig Transduct Target Ther 5, 152.","journal-title":"Sig Transduct Target Ther"},{"key":"3015_CR42","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha, V.K., Lindgren, C.M., Eriksson, K.F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstr\u00e5le, M., Laurila, E., et al. (2003). PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately down-regulated in human diabetes. Nat Genet 34, 267\u2013273.","journal-title":"Nat Genet"},{"key":"3015_CR43","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nrclinonc.2016.26","volume":"13","author":"B O\u2019Leary","year":"2016","unstructured":"O\u2019Leary, B., Finn, R.S., and Turner, N.C. (2016). Treating cancer with selective CDK4\/6 inhibitors. Nat Rev Clin Oncol 13, 417\u2013430.","journal-title":"Nat Rev Clin Oncol"},{"key":"3015_CR44","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2147\/BTT.S166867","volume":"12","author":"YH Pan","year":"2018","unstructured":"Pan, Y.H., Jiao, L., Lin, C.Y., Lu, C.H., Li, L., Chen, H.Y., Wang, Y.B., and He, Y. (2018). Combined treatment with metformin and gefitinib overcomes primary resistance to EGFR-TKIs with EGFR mutation via targeting IGF-1R signaling pathway. BTT Volume 12, 75\u201386.","journal-title":"BTT Volume"},{"key":"3015_CR45","doi-asserted-by":"publisher","first-page":"155516","DOI":"10.1016\/j.metabol.2023.155516","volume":"141","author":"J Park","year":"2023","unstructured":"Park, J., Rah, S.Y., An, H.S., Lee, J.Y., Roh, G.S., Ryter, S.W., Park, J.W., Yang, C.H., Surh, Y.J., Kim, U.H., et al. (2023). Metformin-induced TTP mediates communication between Kupffer cells and hepatocytes to alleviate hepatic steatosis by regulating lipophagy and necroptosis. Metabolism 141, 155516.","journal-title":"Metabolism"},{"key":"3015_CR46","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12943-019-1073-4","volume":"18","author":"S Peng","year":"2019","unstructured":"Peng, S., Wang, R., Zhang, X., Ma, Y., Zhong, L., Li, K., Nishiyama, A., Arai, S., Yano, S., and Wang, W. (2019). EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expression. Mol Cancer 18, 165.","journal-title":"Mol Cancer"},{"key":"3015_CR47","doi-asserted-by":"publisher","first-page":"1610257","DOI":"10.1080\/23723556.2019.1610257","volume":"6","author":"S Qie","year":"2019","unstructured":"Qie, S., and Diehl, J.A. (2019). Glutamine addiction: an achilles heel in esophageal cancers with dysregulation of CDK4\/6. Mol Cell Oncol 6, 1610257.","journal-title":"Mol Cell Oncol"},{"key":"3015_CR48","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.semcancer.2020.01.012","volume":"67","author":"S Qie","year":"2020","unstructured":"Qie, S., and Diehl, J.A. (2020). Cyclin D degradation by E3 ligases in cancer progression and treatment. Semin Cancer Biol 67, 159\u2013170.","journal-title":"Semin Cancer Biol"},{"key":"3015_CR49","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s00109-016-1475-3","volume":"94","author":"S Qie","year":"2016","unstructured":"Qie, S., and Diehl, J.A. (2016). Cyclin D1, cancer progression, and opportunities in cancer treatment. J Mol Med 94, 1313\u20131326.","journal-title":"J Mol Med"},{"key":"3015_CR50","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/s41467-017-01199-8","volume":"8","author":"S Qie","year":"2017","unstructured":"Qie, S., Majumder, M., Mackiewicz, K., Howley, B.V., Peterson, Y.K., Howe, P.H., Palanisamy, V., and Diehl, J.A. (2017). Fbxo4-mediated degradation of Fxr1 suppresses tumorigenesis in head and neck squamous cell carcinoma. Nat Commun 8, 1534.","journal-title":"Nat Commun"},{"key":"3015_CR51","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1038\/s41467-019-09179-w","volume":"10","author":"S Qie","year":"2019","unstructured":"Qie, S., Yoshida, A., Parnham, S., Oleinik, N., Beeson, G.C., Beeson, C.C., Ogretmen, B., Bass, A.J., Wong, K.K., Rustgi, A.K., et al. (2019). Targeting glutamine-addiction and overcoming CDK4\/6 inhibitor resistance in human esophageal squamous cell carcinoma. Nat Commun 10, 1296.","journal-title":"Nat Commun"},{"key":"3015_CR52","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-cellbio-111315-125407","volume":"32","author":"N Raben","year":"2016","unstructured":"Raben, N., and Puertollano, R. (2016). TFEB and TFE3: linking lysosomes to cellular adaptation to stress. Annu Rev Cell Dev Biol 32, 255\u2013278.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"3015_CR53","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nrc2771","volume":"10","author":"T Santarius","year":"2010","unstructured":"Santarius, T., Shipley, J., Brewer, D., Stratton, M.R., and Cooper, C.S. (2010). A census of amplified and overexpressed human cancer genes. Nat Rev Cancer 10, 59\u201364.","journal-title":"Nat Rev Cancer"},{"key":"3015_CR54","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.lungcan.2022.02.010","volume":"166","author":"A Santoro","year":"2022","unstructured":"Santoro, A., Su, W.C., Navarro, A., Simonelli, M., CH Yang, J., Ardizzoni, A., Barlesi, F., Hyoung Kang, J., DiDominick, S., Abdelhady, A., et al. (2022). Phase Ib\/II study of ceritinib in combination with ribociclib in patients with ALK-rearranged non-small cell lung cancer. Lung Cancer 166, 170\u2013177.","journal-title":"Lung Cancer"},{"key":"3015_CR55","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1126\/science.1204592","volume":"332","author":"C Settembre","year":"2011","unstructured":"Settembre, C., Di Malta, C., Polito, V.A., Arencibia, M.G., Vetrini, F., Erdin, S., Erdin, S. U., Huynh, T., Medina, D., Colella, P., et al. (2011). TFEB links autophagy to lysosomal biogenesis. Science 332, 1429\u20131433.","journal-title":"Science"},{"key":"3015_CR56","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature13176","volume":"509","author":"Y Song","year":"2014","unstructured":"Song, Y., Li, L., Ou, Y., Gao, Z., Li, E., Li, X., Zhang, W., Wang, J., Xu, L., Zhou, Y., et al. (2014). Identification of genomic alterations in oesophageal squamous cell cancer. Nature 509, 91\u201395.","journal-title":"Nature"},{"key":"3015_CR57","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., and Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71, 209\u2013249.","journal-title":"CA Cancer J Clin"},{"key":"3015_CR58","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.ccell.2021.03.010","volume":"39","author":"JM Suski","year":"2021","unstructured":"Suski, J.M., Braun, M., Strmiska, V., and Sicinski, P. (2021). Targeting cell-cycle machinery in cancer. Cancer Cell 39, 759\u2013778.","journal-title":"Cancer Cell"},{"key":"3015_CR59","doi-asserted-by":"publisher","first-page":"eaav7171","DOI":"10.1126\/scitranslmed.aav7171","volume":"11","author":"AE Vilgelm","year":"2019","unstructured":"Vilgelm, A.E., Saleh, N., Shattuck-Brandt, R., Riemenschneider, K., Slesur, L., Chen, S. C., Johnson, C.A., Yang, J., Blevins, A., Yan, C., et al. (2019). MDM2 antagonists overcome intrinsic resistance to CDK4\/6 inhibition by inducing p21. Sci Transl Med 11, eaav7171.","journal-title":"Sci Transl Med"},{"key":"3015_CR60","doi-asserted-by":"publisher","first-page":"216155","DOI":"10.1016\/j.canlet.2023.216155","volume":"562","author":"G Wang","year":"2023","unstructured":"Wang, G., Gao, H., Dai, S., Li, M., Gao, Y., Yin, L., Zhang, K., Zhang, J., Jiang, K., Miao, Y., et al. (2023). Metformin inhibits neutrophil extracellular traps-promoted pancreatic carcinogenesis in obese mice. Cancer Lett 562, 216155.","journal-title":"Cancer Lett"},{"key":"3015_CR61","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11427-023-2554-y","volume":"68","author":"J Wang","year":"2025","unstructured":"Wang, J., Zhou, W., Xu, Y., Duan, J., Zhou, Q., Wang, G., Li, L., Xu, C., Wang, W., Cai, S., et al. (2025). Antithetical impacts of deleterious LRP1B mutations in non-squamous and squamous NSCLCs on predicting benefits from immune checkpoint inhibitor alone or with chemotherapy over chemotherapy alone: retrospective analyses of the POPLAR\/OAK and CHOICE-01 trials. Sci China Life Sci 68, 249\u2013262.","journal-title":"Sci China Life Sci"},{"key":"3015_CR62","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/s13046-019-1346-1","volume":"38","author":"Y Wu","year":"2019","unstructured":"Wu, Y., Zheng, Q., Li, Y., Wang, G., Gao, S., Zhang, X., Yan, X., Zhang, X., Xie, J., Wang, Y., et al. (2019). Metformin targets a YAP1-TEAD4 complex via AMPK\u03b1 to regulate CCNE1\/2 in bladder cancer cells. J Exp Clin Cancer Res 38, 376.","journal-title":"J Exp Clin Cancer Res"},{"key":"3015_CR63","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13046-020-01627-6","volume":"39","author":"C Xia","year":"2020","unstructured":"Xia, C., Liu, C., He, Z., Cai, Y., and Chen, J. (2020). Metformin inhibits cervical cancer cell proliferation by modulating PI3K\/Akt-induced major histocompatibility complex class I-related chain a gene expression. J Exp Clin Cancer Res 39, 127.","journal-title":"J Exp Clin Cancer Res"},{"key":"3015_CR64","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41401-020-0416-4","volume":"42","author":"XQ Xu","year":"2021","unstructured":"Xu, X.Q., Pan, X.H., Wang, T.T., Wang, J., Yang, B., He, Q.J., and Ding, L. (2021). Intrinsic and acquired resistance to CDK4\/6 inhibitors and potential overcoming strategies. Acta Pharmacol Sin 42, 171\u2013178.","journal-title":"Acta Pharmacol Sin"},{"key":"3015_CR65","doi-asserted-by":"publisher","first-page":"e202102001","DOI":"10.1083\/jcb.202102001","volume":"220","author":"C Yang","year":"2021","unstructured":"Yang, C., and Wang, X. (2021). Lysosome biogenesis: regulation and functions. J Cell Biol 220, e202102001.","journal-title":"J Cell Biol"},{"key":"3015_CR66","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s13046-021-02012-7","volume":"40","author":"J Yang","year":"2021","unstructured":"Yang, J., Zhou, Y., Xie, S., Wang, J., Li, Z., Chen, L., Mao, M., Chen, C., Huang, A., Chen, Y., et al. (2021). Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer. J Exp Clin Cancer Res 40, 206.","journal-title":"J Exp Clin Cancer Res"},{"key":"3015_CR67","doi-asserted-by":"publisher","first-page":"e201911036","DOI":"10.1083\/jcb.201911036","volume":"219","author":"Q Yin","year":"2020","unstructured":"Yin, Q., Jian, Y., Xu, M., Huang, X., Wang, N., Liu, Z., Li, Q., Li, J., Zhou, H., Xu, L., et al. (2020). CDK4\/6 regulate lysosome biogenesis through TFEB\/TFE3. J Cell Biol 219, e201911036.","journal-title":"J Cell Biol"},{"key":"3015_CR68","doi-asserted-by":"publisher","first-page":"eaax6352","DOI":"10.1126\/sciadv.aax6352","volume":"5","author":"A Yoshida","year":"2019","unstructured":"Yoshida, A., Bu, Y., Qie, S., Wrangle, J., Camp, E.R., Hazard, E.S., Hardiman, G., de Leeuw, R., Knudsen, K.E., and Diehl, J.A. (2019). SLC36A1-mTORC1 signaling drives acquired resistance to CDK4\/6 inhibitors. Sci Adv 5, eaax6352.","journal-title":"Sci Adv"},{"key":"3015_CR69","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41391-018-0085-2","volume":"22","author":"S Zaidi","year":"2019","unstructured":"Zaidi, S., Gandhi, J., Joshi, G., Smith, N.L., and Khan, S.A. (2019). The anticancer potential of metformin on prostate cancer. Prostate Cancer Prostatic Dis 22, 351\u2013361.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"3015_CR70","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1016\/j.molcel.2023.06.004","volume":"83","author":"J Zhang","year":"2023","unstructured":"Zhang, J., Zeng, W., Han, Y., Lee, W.R., Liou, J., and Jiang, Y. (2023). Lysosomal LAMP proteins regulate lysosomal pH by direct inhibition of the TMEM175 channel. Mol Cell 83, 2524\u20132539.e7.","journal-title":"Mol Cell"},{"key":"3015_CR71","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s11427-023-2556-4","volume":"68","author":"C Zheng","year":"2025","unstructured":"Zheng, C., Song, L., Yu, C., Zhu, L., Zhang, J., Wang, N., Liu, M., Li, S., Wang, L., Shen, Z., et al. (2025). Palindrome-mediated DNA nanotubes with cell-specific aptamers to improve targeted antitumor effects and reduce toxicity on non-small cell lung cancer. Sci China Life Sci 68, 454\u2013466.","journal-title":"Sci China Life Sci"},{"key":"3015_CR72","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41419-024-06540-w","volume":"15","author":"XY Zhou","year":"2024","unstructured":"Zhou, X.Y., Lai, Y.H., Zhang, J., Li, Y., Wu, X.M., Yang, Y.Z., Zhang, X.F., Ma, L.Z., Zheng, K.M., Liu, Y.D., et al. (2024). Advanced oxidation protein products attenuate the autophagy-lysosome pathway in ovarian granulosa cells by modulating the ROS-dependent mTOR-TFEB pathway. Cell Death Dis 15, 161.","journal-title":"Cell Death Dis"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-024-3015-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11427-024-3015-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-024-3015-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T16:04:30Z","timestamp":1767801870000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11427-024-3015-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["3015"],"URL":"https:\/\/doi.org\/10.1007\/s11427-024-3015-1","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,23]]},"assertion":[{"value":"18 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest. The protocol was approved by the Laboratory Animal Ethics Committee at the Tianjin Medical University Cancer Institute & Hospital (No.AE-2023008). This study has complied with all relevant ethical regulations for animal experiments. Every effort was made to minimize the numbers and suffering of animals used.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance and ethics"}}]}}